Navigating the gut–metabolite–immune axis: enhancing efficacy and mitigating toxicity of immune checkpoint inhibitors - Poll - MDSpire

Navigating the gut–metabolite–immune axis: enhancing efficacy and mitigating toxicity of immune checkpoint inhibitors

  • By

  • Yu Zhang

  • Shengnan Wang

  • Shuang Chang

  • Yuanyuan Li

  • Yexing Dang

  • Zhihao Wang

  • July 13, 2026

Share

Original Source(s)

Navigating the gut–metabolite–immune axis: enhancing efficacy and mitigating toxicity of immune checkpoint inhibitors

  • by Yu Zhang, Shengnan Wang, Shuang Chang, Yuanyuan Li, Yexing Dang, Zhihao Wang

  • July 13, 2026

Related Content

A metabolic marker–based diagnostic model for precancerous and malignant endometrial lesions in insulin-resistant PCOS women with sonographically suspected endometrial polyps

Integrating polyphenols and exercise in cancer prevention, treatment, and rehabilitation: cellular and molecular mechanisms linking the injury–recovery–musculoskeletal resilience axis

Topical trichloroacetic acid versus electrocautery for treatment of anal intraepithelial neoplasia in people living with HIV: a multicentre, randomised, non-inferiority trial (TECAIN-study)